• NORD Seeks Speakers for 2021 Virtual ‘Living Rare, Living Stronger’ Forum
  • Measuring Procalcitonin in Sputum May Help Manage Flare-ups
  • RHB-204, Oral Treatment for MAC Lung Infections, Put on FDA Fast Track
  • Corticosteroid Use Higher in Children With Bronchiectasis Who Have Asthma
  • Hypertonic Saline May Boost Benefits of Airway Clearance Techniques in Children
  • Endothelial Progenitor Cells (EPCs) Linked to Disease Severity in Study
  • Young Bronchiectasis Patients Less Prepared to Shift to Adult Healthcare, NZ Study Finds
  • Savara Discontinues Apulmiq Program for NCFB Amid Cost-cutting Measures
  • Study Recommends Longer Rest Interval Between 6-min Walk Tests for Non-CF Bronchiectasis Patients
  • Phase 3 ASPEN Trial Testing Brensocatib Now Recruiting; First Patient Dosed
  • NORD Push for Rare Disease Advisory Councils Focus of Dec. 16 Public Meeting
  • Survey Finds COVID-19 Disrupted Care, Well-Being of Rare Disease Patients in Europe